Drug Profile


Alternative Names: THVD-201; THVD-202; Tolenix

Latest Information Update: 25 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator TheraVida
  • Developer SK Chemicals; TheraVida
  • Class Alkaloids; Antispasmodics; Benzhydryl compounds; Cresols
  • Mechanism of Action Muscarinic receptor agonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Overactive bladder

Most Recent Events

  • 01 Sep 2016 SK Chemicals completes a phase-III trial in Overactive bladder in South Korea (PO) (NCT02485067)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Overactive bladder in USA (PO)
  • 10 Aug 2015 No recent reports on development identified - Phase-II for Overactive bladder in Australia, New Zealand (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top